Today the American Academy of Neurology (AAN) will be presenting a leadership in neurology award to Ben Utecht, a National Football League champion who suffered a traumatic brain injury (TBI) that tackled his career in 2009.

Advanced gene sequencing has found a single genetic mutation essential for a brain disorder that has been plaguing Turkish families for centuries.

In the first trial of its kind, a new type of peptide receptor is being targeted in neuroendocrine tumor (NET) imaging, which could reveal previously hidden cancer, according to a study published April 17 in the Journal of Nuclear Medicine.

Data from multiple clinical trials for DaTscan (I-123 FP-CIT Ioflupane) using SPECT shows that the exam is very sensitive for detecting striatal dopaminergic deficits, according to a presentation during the American Academy of Neurology being held April 26 through May 3 in Philadelphia.

The first markets for newly FDA-approved Vizamyl (F-18 flutemetamol), designated for ruling out Alzheimer’s disease and other dementias, were announced during the annual meeting of the American Academy of Neurology this week in Philadelphia, according to a statement from its producer, GE Healthcare.

A potential therapy targeting the misfolded proteins in neurodegenerative disease including Alzheimer;s, Parkinson’s and Huntington’s disease is edging closer to human trials, NeuroPhage Pharmaceuticals announced April 22.

A therapeutic vaccine for Parkinson’s disease and multiple system atrophy (MSA) is the primary objective of a group of leading research teams across Europe, Austrian pharmaceutical company Affiris announced April 28.

The University Hospital 12 de Octubre in Madrid announced April 15 that the institution was using investigational technology to manage Parkinson’s tremor. The robotic glove attaches to patients via electrodes and reduces the hallmark symptom of the neurodegenerative disease.